IDEAS COME FROM THE HEARTArena Pharmaceuticals is expanding our capabilities to study cardiovascular conditions like acute heart failure and coronary microvascular obstruction.
ABOUT ACUTE HEART FAILURE
Acute heart failure (AHF) is a rapid onset of new or worsening symptoms of heart failure. This means your heart can’t pump enough blood. It is a potentially life-threatening condition requiring hospitalization and emergency treatment.
ABOUT CORONARY MICROVASCULAR OBSTRUCTION
Coronary microvascular obstruction (cMVO) is a condition characterized by the failure to achieve full myocardial or microcirculatory reperfusion despite resolution of epicardial coronary occlusion and flow by a percutaneous coronary intervention (PCI). PCI results in activation of platelets and release of serotonin (5-HT), which mediates platelet aggregation and vasoconstriction.